These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 18344762)

  • 1. Barriers to glaucoma drug delivery.
    Ghate D; Edelhauser HF
    J Glaucoma; 2008 Mar; 17(2):147-56. PubMed ID: 18344762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review.
    Yee RW
    Curr Opin Ophthalmol; 2007 Mar; 18(2):134-9. PubMed ID: 17301615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction: new insights on enhancing adherence to topical glaucoma medications.
    Friedman DS
    Ophthalmology; 2009 Nov; 116(11 Suppl):S29. PubMed ID: 19837257
    [No Abstract]   [Full Text] [Related]  

  • 4. A comprehensive perspective on patient adherence to topical glaucoma therapy.
    Tsai JC
    Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
    Jiao J
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical estrogen drops for glaucoma? A long way to go.
    Yin H; Liu X
    Med Hypotheses; 2008; 70(5):1069. PubMed ID: 18178012
    [No Abstract]   [Full Text] [Related]  

  • 7. Side effects of glaucoma medications.
    Detry-Morel M
    Bull Soc Belge Ophtalmol; 2006; (299):27-40. PubMed ID: 16681086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The deleterious effect of certain surface active agents on the ocular surface].
    Ravet O
    Bull Soc Belge Ophtalmol; 2007; (304):145-9. PubMed ID: 17718239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical management of glaucoma: focus on ophthalmologic drug delivery systems of timolol maleate.
    Sah AK; Suresh PK
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):448-459. PubMed ID: 27002850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular hypotensive drugs.
    Willis AM
    Vet Clin North Am Small Anim Pract; 2004 May; 34(3):755-76. PubMed ID: 15110983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approaches to ocular drug delivery.
    Davis JL; Gilger BC; Robinson MR
    Curr Opin Mol Ther; 2004 Apr; 6(2):195-205. PubMed ID: 15195932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimizing systemic absorption of topically administered ophthalmic drugs.
    Urtti A; Salminen L
    Surv Ophthalmol; 1993; 37(6):435-56. PubMed ID: 8100087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery systems for topical ophthalmic medication.
    Halberg GP; Kelly SE; Morrone M
    Ann Ophthalmol; 1975 Sep; 7(9):1199-1204, 1207-9. PubMed ID: 1163927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
    Myles ME; Neumann DM; Hill JM
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication.
    Salyani A; Birt C
    Can J Ophthalmol; 2005 Apr; 40(2):170-4. PubMed ID: 16049530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact lenses for drug delivery.
    Ciolino JB; Dohlman CH; Kohane DS
    Semin Ophthalmol; 2009; 24(3):156-60. PubMed ID: 19437351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New systems of drug administration through a topical ocular administration approach].
    Herrero Vanrell R
    Arch Soc Esp Oftalmol; 2001 Mar; 76(3):143-4. PubMed ID: 11283777
    [No Abstract]   [Full Text] [Related]  

  • 18. The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies.
    Flach AJ
    Trans Am Ophthalmol Soc; 2008; 106():138-45; discussion 145-8. PubMed ID: 19277229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmic drug discovery.
    Clark AF; Yorio T
    Nat Rev Drug Discov; 2003 Jun; 2(6):448-59. PubMed ID: 12776220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimizing the systemic effects of glaucoma medications.
    Farrell TA
    Geriatrics; 1991 May; 46(5):61-4, 73. PubMed ID: 2029975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.